baber/WOPTO huggingface dataset:
Patent BR-PI0909708-B1 (BR)
Title: Métodos para calcular mudanças de tempo para detectar mudanças de material em estratos contendo petróleo durante as atividades de produção de petróleo, e para determinar ou detectar uma mudança em uma propriedade geofísica de uma região subterrânea, e, aparelho
Inventor: ESPEN OEN LIE
IPC: G01V1/28
Filed: 2009-03-31
Abstract: métodos para calcular mudanças de tempo para detectar mudanças de material em estratos contendo petróleo durante as atividades de produção de petróleo, e para determinar ou detectar uma mudança em uma propriedade geofísica de uma região subterrânea, e, aparelho a invenção é um método para correspondência de mudança de tempo de reflexão de um primeiro e um segundo conjunto de dados de reflexão sísmica (1 o, 30), compreendendo primeiro e segundos traços de reflexão sísmica ( 1, 3) com séries de reflexões sísmica genericamente correspondentes (11, 31 ). o primeiro e segundo conjuntos de dados sísmicos (10, 30) são adquiridos com uma separação no tempo estendendo-se através de meses ou anos. o segundo conjunto de dados sísmicos (30) compreende pelo menos uma série estendendo-se lateralmente (40) de novos eventos sísmicos (4) não presentes no primeiro conjunto de dados sísmicos (10). as mudanças do tempo de reflexão (22) são calculadas como requerido para igualar as reflexões sísmicas (31) dos segundos traços de reflexão (3) dos segundos dados de reflexão sísmica (11) dos primeiros traços de reflexão (2). as mudanças de tempo calculadas são conduzidas em ditos segundo traços de reflexão (3). os cálculos das mudanças de tempo (22) são feitos calculando-se os coeficientes das estimativas da função de base.
Patent BR-PI0912068-B1 (BR)
Title: Método e sistema para armazenamento, enrolamento e distribuição de uma tubulação
Inventor: MICHAEL W N WILSON
IPC: F16L1/12
Filed: 2009-08-06
Abstract: método e sistema para armazenamento, enrolamento e distribuição de uma tubulação a presente invenção refere-se, em geral, a tubulações e, mais particularmente, diz respeito ao armazenamento, à entrega e à bobinagem de tubulações que foram pré-montadas para serem assentadas em um local remoto, como tubulações submarinas usadas em sistemas de produção de poço marítimos. o método para o armazenamento de uma tubulação (l), acima de uma área geométrica selecionada (200), sendo que o método compreendendo as etapas de: selecionar um raio de flexão mínimo (209) da tubulação (l); determinar um comprimento máximo para a tubulação (l); definir uma trajetória linear de enroscamento fixa (203) em um espaço vertical acima da área geométrica selecionada (200), sendo que a trajetória (203) possui voltas de raios maiores que o raio de flexão mínimo (209) selecionado da tubulação (l), e um comprimento maior que o comprimento máximo determinado para a tubulação (l); e executar um trajeto da tubulação (l) pela trajetória de enroscamento fixa (203) até que toda a tubulação (l) esteja na trajetória de enroscamento (203).
Patent BR-PI0915671-B1 (BR)
Title: Correia sem fim para uso em um sistema de formação de imagem digital
Inventor: CHRIS J TICE
IPC: G03G15/16
Filed: 2009-06-29
Abstract: correia sem fim para uso em um sistema de formação de imagem digital uma correia sem fim para uso em sistemas de formação de imagem digital digital é fornecida tendo nivelamento uniforme de borda a borda, e espessura circunferencial precisa e de borda a borda. as camadas compreendendo a correia podem ser adaptadas conforme o desejado para uso em gravação de imagem, transferência de imagem ou operações de transporte de folhas. em uma forma de realização, a correia inclui uma camada de base elastomérica, uma camada de suporte de reforço, e uma lona superficial elastomérica. a correia é preferivelmente fabricada mediante a construção das camadas sobre uma obra e depois a cura das camadas.
Patent BR-PI0921551-B1 (BR)
Title: Distribuidor e unidade de recarga
Inventor: CHRISTOPHER LEONARD PADAIN
IPC: A47K5/12
Filed: 2009-11-17
Abstract: distribuidor e unidade de recarga um distribuidor compreendendo uma unidade de base com um mecanismo de atuação para a distribuição de líquido e uma unidade de recarga passível de inserção numa unidade de base em uma configuração invertida, com a sua saída mais baixa para o fornecimento de líquidos para a unidade de base. a unidade de recarga compreende uma parede anelar projetando-se na unidade de recarga e definindo uma saída da unidade de recarga; a parede anelar sendo fechável em sua extremidade interior por meio de um elemento de válvula que tende para a parede anelar. a unidade de base compreende uma torneira oca e uma vedação anelar envolvente e que se distancia do topo da torneira pela qual a inserção da unidade de recarga na unidade de base faz com que a torneira entre na parede anelar e levante o elemento de válvula da parede anelar para definir uma via de fluxo a partir da unidade de recarga, através de pelo menos uma porção de corte de saída formada no topo da torneira e/ou na parte inferior do elemento de válvula e para baixo pela torneira, e com que o selo anelar cause a vedação entre a torneira e a parede anelar.
Patent BR-PI0922524-B1 (BR)
Title: estrutura semelhante a coágulo de fibrina, e, usos de uma estrutura semelhante a coágulo de fibrina, e de uma preparação de uma estrutura semelhante a coágulo de fibrina
Inventor: ANDREAS GOPPELT
IPC: A61L24/04
Filed: 2009-12-11
Abstract: ESTRUTURA SEMELHANTE A COÁGULO DE FIBRINA, EMPLASTRO HEMOSTÁTICO, SISTEMA, DE SERINGA DE DOIS COMPONENTES, USOS DE UMA ESTRUTURA SEMELHANTE A COÁGUO DE FIBRINA, E DE UMA PREPARAÇÃO DE UMA ESTRUTURA SEMELHANTE A COÁGULO DE FIBRINA A presente invenção fornece uma preparação compreendendo fibrinogênio e um polissacarídeo sulfatado como uma composição de um componente ou como um kit de partes compreendendo fibrinogênio e polissacarídeo sulfatado como componentes separados. A presente invenção também fornece uma estrutura semelhante a um coágulo de fibrina obtida por um processo definido, um emplastro hemostático, um sistema de seringa de dois componentes e vários usos das preparações descritas, estruturas semelhantes a coágulo de fibrina e emplastros.
Patent BR-PI1105958-B1 (BR)
Title: Dispositivo com microcircuitos de controle de execução de pelo menos uma função interna protegida embarcada no mesmo e processo para tal
Inventor: AURÉLIEN RABOISSON
IPC: G06F21/34
Filed: 2011-12-08
Abstract: dispositivo com microcircuitos de controle de execução de pelo menos uma função interna protegida embarcada no mesmo e processo para tal a invenção tem notadamente por objeto o controle de execução de funções internas e de aplicações protegidas embarcadas em um cartão com microcircuitos para terminal móvel. o controle de uma função interna protegida é diretamente efetuado no cartão com microcircuitos. depois de ter detectado (400) um comando de colocação em vigilância do cartão, a partir de uma informação recebida de um terminal móvel no qual é conectado o cartão, pelo menos uma indicação relativa à execução da função interna protegida é analisada (415). se a função interna protegida é suscetível de ser afetada pela execução do comando de colocação em vigilância, a execução do comando de colocação em vigilância é diferida (410).
Patent BR-PI1106571-B1 (BR)
Title: Equipamento micro extrator de gases de pirólise e seu método de operação
Inventor: EDUARDO SIQUEIRA DE ARAUJO CONDE
IPC: C10J1/00
Filed: 2011-12-15
Abstract: equipamento micro extrator de gases de pirólise e seu método de operação. é relatado na presente invenção um equipamento micro extrator de gases de pirólise os quais se encontram encerrados em um micro-tubo (mt) de pirólise do tipo mssv (micro scale sealed vessel), sem estar ligado à linha de aparelhos analisadores como, por exemplo, espectrômetros de massa e cromatográficos de gá de relação isotópica. um método de operação para extração do gás pirolisado por meio do referido aparelho também é descrito
Patent EA-002983-B1 (EA)
Title: METHOD FOR ALTERING HUMORAL IMMUNE RESPONSE BY LT-beta-R BLOCKING AGENT
Inventor: BROWNING JEFFREY
IPC: A61K45/00
Filed: 1997-10-24
Abstract: 1. A method for altering the humoral immune response in an animal comprising the step of administering a pharmaceutical composition which comprises a therapeutically effective amount of a LT-β-R blocking agent. 2. The method according to claim 1, wherein the LT-β-R blocking agent is selected from the group consisting of soluble lymphotoxin-β receptor, an antibody directed against LT-β receptor, and an antibody directed against surface LT ligand. 3. The method according to claim 1, wherein the animal is a mammal. 4. The method according to claim 3, wherein the mammal is a human. 5. The method according to claim 2, wherein the LT-β-R blocking agent comprises a soluble lymphotoxin-β receptor having a ligand binding domain that can selectively bind to a surface LT ligand. 6. The method according.to claim 5, wherein the soluble lymphotoxin-β receptor comprises a human immunoglobulin Fc domain. 7. The method according to claim 2, wherein the LT-β-R blocking agent comprises a monoclonal antibody directed against LT-β receptor. 8. The method according to claim 7, wherein the composition is administered in an amount sufficient 10 coat LT-β receptor-positive cells for about 1 to about 14 days. 9. The method according to claim 7, wherein the LT-β-R blocking agent comprises and-human LT-β-R mAb BDA8. 10. The method according to claim 2, wherein the LT-β-R blocking agent comprises a monoclonal antibody directed against surface LT ligand. 11. The method according to claim 10, wherein the composition is administered in an amount sufficient to coat surface LT Uganda-positive cells for 1 to 14 days. 12. The method according to claim 10, wherein the antibody is directed against a subunit of the LT ligand. 13. The method according to claim 10, wherein the LT-β-R blocking agent comprises anti-human mAb B9. 14. The method according to claim 10, wherein the LT-β-R blocking agent comprises a monoclonal antibody directed against a muhne surface LT ligand. 15. The method of claim 1 further comprising a pharmaceutically acceptable carrier or adjuvant. 16. The method according to claim 1, wherein the humoral immune response is inhibited. 17. The method of claim 1 wherein said patient is infected with human immunodeficiency virus. 18. The method of claim 17 further comprising the co-administration of an additional anti-viral agent.
Patent EA-002602-B1 (EA)
Title: Method for treating infections caused by staphylococcus aureus
Inventor: NICAS THALIA IOANNA
IPC: A61K38/14
Filed: 1998-08-18
Abstract: 1. A method of treating an infectious disease in a warm blooded animal, the method comprises administering to the animal an effective amount of N<DISACC>-(4-(4-chlorophenyl)benzyl)A82846B or a salt thereof, wherein the disease is attributable to a strain of Staphylococcus aureus which (1) has reduced glycopeptide sensitivity, and (2) is Van A and Van B negative. 2. A method of Claim 1 in which the strain of Staphylococcus aureus is additionally resistant to methicillin. 3. A method of Claim 1 or 2 in which the strain of Staphylococcus aureus is glycopeptide resistant. 4. A method of Claim 1 or 2 in which the strain of Staphylococcus aureus is Mu50.
Patent EA-005331-B1 (EA)
Title: Press for dewatering a humid substance, in particular residual reuse
Inventor: WIDMER CHRISTIAN
IPC: B30B9/12
Filed: 2002-09-03
Abstract: The invention relates to a press for dewatering a humid substance, in particular residual refuse. Said press comprises a screw conveyer, which is used to mechanically compress the residual refuse. The humid substance is exposed to a drying medium, preferably to compressed air or a vacuum, whilst being transported by the screw conveyer, in such a way that the humidity is evacuated from the press.
Patent EA-006662-B1 (EA)
Title: Method of esophagoplasty using gastic tube
Inventor: DZHAFAROV CHERKEZ MAMISH OGLY
IPC: A61F2/04
Filed: 2004-06-01
Abstract: The invention relates to medicine, in particular to surgery and can be used in esophagoplastic operations with scar structure after surgical bum.The inventive aim is to increase healing period of anastomosis by improving blood supply of an autotransplantant.The method is characterized in that the method of esophagoplasty using a gastic tube comprises the steps of applying gastrostoma nearer to a lesser curvature of stomach and forming isoperistaltic tube cut out from all greater curvature of stomach and according to the invention the left artery and vein are singled out, tied out and cut prior to gastrostoma application.
Patent EA-011282-B1 (EA)
Title: Bacterial packaging strains useful for generation and production of recombinant double-stranded rna nucleocapsids and uses thereof
Inventor: HONED DAVID MICHAEL
IPC: C07H21/02
Filed: 2005-11-23
Abstract: Bacterial packaging strains useful for generating recombinant double-stranded RNA nucleocapsids (rdsRNs) are provided. The packaging strains are useful for the production of RNA encoding vaccine antigens, bioactive proteins, immunoregulatory proteins, antisense RNAs, and catalytic RNAs in eukaryotic cells or tissues. Recombinant ssRNA is introduced into the strains and packaged to form rdsRNs de novo.
Patent EA-016343-B1 (EA)
Title: Activating fluorinated supports with iron-based non-metallocene complexes
Inventor: PRADES FLORAN
IPC: C08F4/02
Filed: 2006-07-26
Abstract: The present invention discloses an active supported catalyst system comprising: a) an iron-based non-metallocene catalyst component; b) an alkylating agent; c) an activating functionalised and fluorinated support. It also discloses a method for preparing said active supported catalyst system and its use in the polymerisation of olefins.
Patent EA-017925-B1 (EA)
Title: 1H-IMIDAZO[4,5-b]PYRAZIN DERIVATIVES
Inventor: MUCI ALEX
IPC: A61K31/498
Filed: 2007-08-01
Abstract: The invention relates to a chemical composition selected from compounds of Formula I and compounds of Formula IIand pharmaceutically acceptable salts thereof, wherein Ris selected from Calkenyl and Calkynyl; Ris hydrogen; and Ris selected from a group comprising 3-pentyl, cyclohexyl, izopropyl and 1-morpholinobutane-2-yl; provided that Ri is not hex-1-enyl; a chemical composition selected from a group comprising 1-[(1R)-1-(morpholin-4-ylmethyl)propyl]-6-ethynylimidazo[4,5-b]pyrazin-2-ol; 1-(pentan-3-yl)-6-(prop-1-ynyl)-1H-imidazo[4,5-b]pyrazin-2-ol; and 6-ethynyl-1-(pentan-3-yl)-1H-imidazo[4,5-b]pyrazin-2-ol; a chemical composition selected from a group comprising (E)-1-(pentan-3-yl)-6-(prop-1-enyl)-1H-imidazo[4,5-b]pyrazin-2-ol; (E)-1-cyclohexyl-6-(prop-1-enyl)-1H-imidazo[4,5-b]pyrazin-2-ol; (E)-1-isopropyl-6-(prop-1-enyl)-1H-imidazo[4,5-b]pyrazin-2-ol; (Z)-1-(pentan-3-yl)-6-(prop-1-enyl)-1H-imidazo[4,5-b]pyrazin-2-ol; (Z)-1-cyclohexyl-6-(prop-1-enyl)-1H-imidazo[4,5-b]pyrazin-2-ol; (Z)-1-isopropyl-6-(prop-1-enyl)-1H-imidazo[4,5-b]pyrazin-2-ol; 1-(ethylpropyl)-6-vinylimidazo[4,5-b]pyrazin-2-ol; and 1-(ethylpropyl)-6-(1-methylvinyl)imidazo[4,5-b]pyrazin-2-ol; a chemical composition selected from a group comprising 1-(pentan-3-yl)-6-(prop-1-enyl)-1H-imidazo[4,5-b]pyrazin-2(3H)-one; and 6-ethynyl-1-(pentan-3-yl)-1H-imidazo[4,5-b]pyrazin-2(3H)-one; a chemical composition selected from a group comprising (E)-1-(pentan-3-yl)-6-(prop-1-enyl)-1H-imidazo[4,5-b]pyrazin-2(3H)-one; (E)-1-cyclohexyl-6-(prop-1-enyl)-1H-imidazo[4,5-b]pyrazin-2(3H)-one; (E)-1-isopropyl-6-(prop-1-enyl)-1H-imidazo[4,5-b]pyrazin-2(3H)-one; (Z)-1-(pentan-3-yl)-6-(prop-1-enyl)-1H-imidazo[4,5-b]pyrazin-2(3H)-one; (Z)-1-cyclohexyl-6-(prop-1-enyl)-1H-imidazo[4,5-b]pyrazin-2(3H)-one; (Z)-1-isopropyl-6-(prop-1-enyl)-1H-imidazo[4,5-b]pyrazin-2(3H)-one; or pharmaceutically acceptable salts thereof. Moreover, a pharmaceutically acceptable composition is proposed for treating a neuromuscular disease, comprising a pharmaceutically acceptable carrier and a chemical composition. A method is also proposed for treating a patient suffering from a neuromuscular disease, comprising administering a patient a therapeutically effective amount of the chemical composition. Wherein the neuromuscular disease can be both amyotrophic lateral sclerosis (ALS) and heavy pseudoparalytic myasthenia.
Patent EA-015868-B1 (EA)
Title: Hollow core construction unit and method for producing thereof
Inventor: BELEVICH VALERIJ NIKOLAEVICH
IPC: B28B3/00
Filed: 2009-08-10
Abstract: The invention relates to construction industry and can be used for fabricating hollow core construction items from prefabricated and reinforced concrete. Hollow core construction item comprises gripping loops, the ends of which are arranged in concrete body channel and provided with flat caps forming closed space in the channel between said caps and filled with concrete mass in which loop ends are arranged. The gripping loops with caps are mounted in a channel through holes according to marking in concrete body by crushing concrete in the upper surface of item until a passage is formed in a channel having half length of the loop with subsequent pouring concrete mixture through the hole forming concrete mass inside hollow channel between caps. The inventive result is aimed at lesser material consumption for arranging gripping loops, increasing their carrying capacity, reducing labor content during rigging and providing convenient grip of said hollow core construction item.
Patent EA-021064-B1 (EA)
Title: Continuous diploid avian cell lines derived from embryons, process for obtaining same and use thereof for the production of viral vaccines, recombinant proteins and peptides
Inventor: GUEHENNEUX FABIENNE
IPC: A61K39/145
Filed: 2008-04-23
Abstract: The present invention relates to the development and manufacturing of viral vaccines. In particular, the invention relates to the field of industrial production of viral vectors and vaccines, more in particular to the use of avian embryonic stem cells, preferably the Ebxcell line derived from duck embryonic stem cells, for the production of viral vectors and viruses. The invention is particularly useful for the industrial production of viral vaccines to prevent viral infection of humans and animals.
Patent EA-019120-B1 (EA)
Title: Cold drawn low carbon steel filament and method of manufacturing said filament
Inventor: DEL RIO RODRIGUEZ JAVIER
IPC: C21D7/02
Filed: 2009-02-25
Abstract: A steel filament adapted for the reinforcement of elastomer or for thermoplastic products has a carbon content ranging up to 0.20 per cent by weight. The steel filament is provided with a coating promoting the adhesion with elastomer or thermoplastic products. The steel filament is drawn until a final diameter of less than 0.60 mm and a final tensile strength of more than 1200 MPa. Intermediate heat treatments are avoided so that the “carbon footprint” of the steel filament is substantially reduced.
Patent EA-019825-B1 (EA)
Title: Method and system for the production of hard plaster
Inventor: GOECKE VOLKER
IPC: C04B11/00
Filed: 2009-09-11
Abstract: The invention relates to a method for the production of hard plaster made from calcined beta hemihydrate plaster, comprising adding of plaster material mainly consisting of beta hemihydrate plaster to a post reactor (3), after-treating in the post reactor (3) for forming hard plaster, wherein the beta hemihydrate plaster is directly converted into alpha hemihydrate plaster at a temperature above the calcining temperature of 95°C , removing the hard plaster from the post reactor (3), and cooling down. During the adding of the plaster material to the post reactor (3) the temperature is adjusted to at least the calcining temperature, the conversion is carried out in the post reactor (3) at a dwell time of less than 30 minutes while externally adding water vapor, and the temperature and the pressure in the post reactor (3) are regulated such that the temperature is at least 95°C and an overpressure is present.
Patent EA-022284-B1 (EA)
Title: Melting furnace
Inventor: ALEXEEV ALEXANDER ALEXEEVICH
IPC: F27B7/00
Filed: 2010-07-08
Abstract: The invention relates to furnaces for melting metal-containing wastes and applying metallic coatings by thermodiffusion (sherardization), and may be utilized for the extraction of non-ferrous metals. In a melting furnace which includes a base (2) mounted on a foundation (1), a body (3) mounted on the base (2) and provided with a roof (4) and a door (5), a removable melting drum (6) disposed in the body (3) and made to permit mounting on a cantilever drive shaft (7), and also a heater (9) mounted on the body (3) by means of hinges (12), the base (2) is mounted on the foundation (1) by means of a hinge (10) with a horizontal axis of rotation perpendicular to the axis of rotation of the drum (6); the heater (9) may be provided with means (13) permitting reciprocatory movement thereof. The arrangement makes it possible to increase the melt surface area, as a result of which the capture of globules of metal from the charge is increased, the melting time is reduced, the service life of the melting drum is increased, and the yield of metal is enhanced; removal of the melting drum from the drive shaft is simplified; furthermore the possibility is provided of applying metallic coatings by thermodiffusion in cases where the length of the part being treated is close to the depth of the drum.
Patent EA-023079-B1 (EA)
Title: Process for preparing irinotecan liposomal form (variants)
Inventor: SHOBOLOV DMITRIJ LVOVICH
IPC: A61K31/4745
Filed: 2012-12-24
Abstract: The invention relates to pharmacology. In general form the disclosed variants of preparing anti-tumour drug in liposomal form presuppose obtaining lipid film based on phospholipids and cholesterol, drying the film until solvent is removed, hydration with buffer solution on ultrasound bath, extrusion with creation of hydrogen ion gradient between internal and external medium of liposomes, and adding irinotecan hydrochloride to the obtained emulsion with the following sterile filtration and freeze-drying or aseptic pouring of the obtained product into vials for storage in liquid form. The disclosed variants are aimed at increasing quality of the obtained product, manufacturability of the preparation process and drug stability during storage.
Patent EA-022642-B1 (EA)
Title: Acceleration protection suit
Inventor: REINHARD ANDREAS
IPC: B64D10/00
Filed: 2011-11-18
Abstract: The suit according to the invention consists of a sheath of a sparingly expansible textile material. This sheath has fastened in it, and on it, by sewing or adhesive bonding or welding, compartments which are formed by virtue of the sheath being doubled, in that a strip of textile material is applied to the inside, or in the second case to the outside, of the sheath, and therefore it is connected to the sheath if only along its periphery. These compartments likewise consist of textile materials, in the first case of the same material as the sheath, and in the second case of an expansible knitted fabric. Flexible tubes, for example made of an elastomer, which expand under pressure are introduced into these compartments. The first-mentioned compartments (9), with textile material which can expand on one side, act as so-called "spacers" and act as displacers for tightening the protective suit over the topography of the individual wearer's body. The second-mentioned compartments (10) act as so-called "muscles" and press locally onto the wearer's body. The compartments (10) are drawn together and thus tighten the sheath and generate an altitude-optimized pressure. These second-mentioned compartments (10) thus tighten the acceleration protection suit to an increasing extent until the tension s around the wearer's body builds up the internal pressure which is necessary at the current time. This protective suit has a reliable altitude protection function, provides optimum G-force protection, can be ventilated for cooling purposes and provides additional buoyancy when immersed in water.